A posthoc analysis was conducted on all IOP measurements , except the immediate 30-min postinjection , from all subjects randomised to pegaptanib 0.3 mg or sham injections continuously in the first 2years of the Vascular endothelial growth factor Inhibition Study in Ocular Neovascularisation ( V.I.S.I.O.N. ) study .